Roger M. Kurlan
#146,079
Most Influential Person Now
Roger M. Kurlan's AcademicInfluence.com Rankings
Roger M. Kurlanmedical Degrees
Medical
#2754
World Rank
#3187
Historical Rank
Neurology
#259
World Rank
#339
Historical Rank
Roger M. Kurlanphilosophy Degrees
Philosophy
#7867
World Rank
#11142
Historical Rank
Logic
#4903
World Rank
#6241
Historical Rank
Download Badge
Medical Philosophy
Why Is Roger M. Kurlan Influential?
(Suggest an Edit or Addition)Roger M. Kurlan's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease. (1993) (1186)
- Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline. (2002) (975)
- Sequence Variants in SLITRK1 Are Associated with Tourette's Syndrome (2005) (959)
- Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial. Parkinson Study Group. (2000) (921)
- Effect of deprenyl on the progression of disability in early Parkinson's disease. (1989) (886)
- Neuropathology of nondemented aging: Presumptive evidence for preclinical Alzheimer disease (2009) (621)
- Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial. (2004) (609)
- Current concepts (2006) (460)
- Lifetime prevalence, age of risk, and genetic relationships of comorbid psychiatric disorders in Tourette syndrome. (2015) (453)
- Treatment of ADHD in children with tics: a randomized controlled trial. (2002) (351)
- Gabapentin's Effects on Hot Flashes in Postmenopausal Women: A Randomized Controlled Trial (2003) (327)
- Ziprasidone treatment of children and adolescents with Tourette's syndrome: a pilot study. (2000) (314)
- A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit. (2014) (294)
- Partitioning the Heritability of Tourette Syndrome and Obsessive Compulsive Disorder Reveals Differences in Genetic Architecture (2013) (280)
- A focus on the synapse for neuroprotection in Alzheimer disease and other dementias (2004) (268)
- A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease (2012) (258)
- Contemporary assessment and pharmacotherapy of Tourette syndrome (2006) (257)
- The AMPA receptor antagonist NBQX has antiparkinsonian effects in monoamine‐depleted rats and MPTP‐treated monkeys (1991) (249)
- The behavioral spectrum of tic disorders: A community-based study (2002) (241)
- Anxiety and Parkinson's disease. (1996) (224)
- Longitudinal outcome of Parkinson’s disease patients with psychosis (2003) (219)
- Prevalence of tics in schoolchildren and association with placement in special education (2001) (208)
- The Tourette Syndrome Diagnostic Confidence Index (1999) (206)
- Atomoxetine treatment in children and adolescents with ADHD and comorbid tic disorders (2005) (203)
- Quetiapine for agitation or psychosis in patients with dementia and parkinsonism (2007) (200)
- A multicenter double‐blind placebo‐controlled trial of pergolide as an adjunct to sinemet® in Parkinson's disease (1994) (194)
- Serotonin syndrome and the combined use of deprenyl and an antidepressant in Parkinson's disease (1997) (187)
- Tourette syndrome: Evolving concepts (2011) (181)
- Erratic gastric emptying of levodopa may cause “random” fluctuations of parkinsonian mobility (1988) (176)
- A survey of antidepressant drug use in Parkinson's disease (1997) (173)
- Normal pressure hydrocephalus: Diagnosis and treatment (2008) (170)
- The pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection (PANDAS) etiology for tics and obsessive-compulsive symptoms: hypothesis or entity? Practical considerations for the clinician. (2004) (165)
- Antiparkinsonian effects of remacemide hydrochloride, a glutamate antagonist, in rodent and primate models of Parkinson's disease (1994) (154)
- Streptococcal Infection and Exacerbations of Childhood Tics and Obsessive-Compulsive Symptoms: A Prospective Blinded Cohort Study (2008) (151)
- Duodenal delivery of levodopa for on‐off fluctuations in parkinsonism: Preliminary observations (1986) (151)
- Practice guideline: Idiopathic normal pressure hydrocephalus: Response to shunting and predictors of response (2015) (146)
- Hereditary ferritinopathy: a novel mutation, its cellular pathology, and pathogenetic insights. (2005) (144)
- The immunobiology of Tourette's disorder, pediatric autoimmune neuropsychiatric disorders associated with Streptococcus, and related disorders: a way forward. (2010) (141)
- The human immune response to streptococcal extracellular antigens: clinical, diagnostic, and potential pathogenetic implications. (2010) (141)
- Preliminary examination of the comorbidity of anxiety and depression in Parkinson's disease. (1992) (140)
- Disabling repetitive behaviors in Parkinson's disease (2004) (140)
- Sensory tics in Tourette's syndrome (1989) (133)
- De Novo Coding Variants Are Strongly Associated with Tourette Disorder (2017) (125)
- Handbook of Tourette's syndrome and related tic and behavioral disorders (1993) (125)
- Cross-disorder genome-wide analyses suggest a complex genetic relationship between Tourette's syndrome and OCD. (2015) (123)
- Evidence for atypical depression in Parkinson's disease. (1988) (122)
- Tourette syndrome in youth with and without obsessive compulsive disorder and attention deficit hyperactivity disorder (2012) (120)
- Genome scan for Tourette disorder in affected-sibling-pair and multigenerational families. (2007) (119)
- Linkage disequilibrium between an allele at the dopamine D4 receptor locus and Tourette syndrome, by the transmission-disequilibrium test. (1996) (118)
- Tourette's syndrome and ‘PANDAS’ Will the relation bear out? (1998) (115)
- Myoclonus-dystonia, obsessive-compulsive disorder, and alcohol dependence in SGCE mutation carriers (2007) (112)
- Dopamine transporter imaging is associated with long‐term outcomes in Parkinson's disease (2012) (110)
- Copy number variation in obsessive-compulsive disorder and tourette syndrome: a cross-disorder study. (2014) (109)
- Oral levodopa dose‐response study in MPTP‐induced hemiparkinsonian monkeys: Assessment with a new rating scale for monkey parkinsonism (1991) (109)
- Duodenal and gastric delivery of levodopa in parkinsonism (1988) (108)
- Non-obscene complex socially inappropriate behavior in Tourette's syndrome. (1996) (107)
- Cerebrospinal fluid levels of quinolinic acid in Huntington's disease and schizophrenia (1988) (106)
- Segregation and linkage analyses of Tourette's syndrome and related disorders. (1990) (105)
- Developing a stable bilateral model of parkinsonism in rhesus monkeys (1993) (105)
- Tourette's syndrome (1989) (104)
- Genome-wide association study of Tourette Syndrome (2012) (102)
- The management of tics (2009) (102)
- Streptococcal upper respiratory tract infections and exacerbations of tic and obsessive-compulsive symptoms: a prospective longitudinal study. (2011) (101)
- A controlled clinical trial of baclofen as protective therapy in early huntington's disease (1989) (100)
- Bilineal transmission in Tourette's syndrome families (1994) (98)
- Moving from PANDAS to CANS. (2012) (97)
- Genome scan for linkage to Gilles de la Tourette syndrome. (1994) (95)
- Myoclonus dystonia (2002) (93)
- The Ups and Downs of Parkinson Disease: A Prospective Study of Mood and Anxiety Fluctuations (2004) (91)
- Clinical practice. Tourette's Syndrome. (2010) (91)
- Familial Tourette's syndrome (1986) (89)
- Embryonic mesencephalic grafts increase levodopa‐induced forelimb hyperkinesia in parkinsonian rats (2003) (89)
- Progress in the search for genetic linkage with Tourette syndrome: an exclusion map covering more than 50% of the autosomal genome. (1991) (87)
- School problems in Tourette's syndrome. (1996) (86)
- Parkinson disease and incidental Lewy body disease (2015) (83)
- Neuroleptic malignant syndrome. (1984) (82)
- Hypothesis III. Tourette syndrome is only one of several causes of a developmental basal ganglia syndrome. (1997) (81)
- A D1 Receptor Antagonist, Ecopipam, for Treatment of Tics in Tourette Syndrome (2014) (81)
- Tourette's syndrome in a special education population (1994) (78)
- Movement Disorders after Stroke in Adults: A Review (2012) (78)
- A controlled trial of deprenyl in children with Tourette's syndrome and attention deficit hyperactivity disorder (1996) (77)
- A pilot controlled study of fluoxetine for obsessive-compulsive symptoms in children with Tourette's syndrome. (1993) (76)
- Parkinson's disease and dementia with Lewy bodies: One disease or two? (2002) (76)
- Myoclonus dystonia: Possible association with obsessive–compulsive disorder and alcohol dependence (2002) (76)
- Randomized, Double-Blind, Placebo-Controlled Trial Demonstrates the Efficacy and Safety of Oral Aripiprazole for the Treatment of Tourette's Disorder in Children and Adolescents (2017) (75)
- De Novo Sequence and Copy Number Variants Are Strongly Associated with Tourette Disorder and Implicate Cell Polarity in Pathogenesis (2018) (74)
- Levodopa responsiveness in disorders with parkinsonism: A review of the literature (2007) (73)
- Relationship between mood and motor fluctuations in Parkinson's disease. (2001) (73)
- A controlled trial of propoxyphene and naltrexone in patients with tourette's syndrome (1991) (73)
- Hypothesis II: Tourette's syndrome is part of a clinical spectrum that includes normal brain development. (1994) (72)
- Gilles de la Tourette syndrome is not linked to D2-dopamine receptor. (1990) (71)
- “Levodopa phobia”: A new iatrogenic cause of disability in Parkinson disease (2005) (69)
- A major locus for myoclonus-dystonia maps to chromosome 7q in eight families. (2000) (68)
- Indications of linkage and association of Gilles de la Tourette syndrome in two independent family samples: 17q25 is a putative susceptibility region. (2004) (67)
- Long-term follow-up of a randomized AAV2-GAD gene therapy trial for Parkinson's disease. (2017) (66)
- Severity of Tourette's syndrome in one large kindred. Implication for determination of disease prevalence rate. (1987) (66)
- Movement disorders in Alzheimer's disease: More rigidity of definitions is needed (2000) (65)
- The pathogenesis of Tourette's syndrome. A possible role for hormonal and excitatory neurotransmitter influences in brain development. (1992) (64)
- Do serotonin reuptake inhibitor antidepressants worsen Parkinson's disease? A retrospective case series (1999) (60)
- Neurosurgical treatment of severe obsessive‐compulsive disorder associated with Tourette's syndrome (1990) (59)
- Assistive devices for gait in Parkinson's disease. (2007) (58)
- Features Resembling Tourette's Syndrome in Developmental Stutterers (1998) (58)
- Understanding disability in Tourette syndrome (2009) (57)
- Gilles de la Tourette’s syndrome in special education schools: a United Kingdom study (1997) (57)
- Atomoxetine Treatment of ADHD in Children With Comorbid Tourette Syndrome (2008) (55)
- MR volumetric analysis of the human basal ganglia: normative data. (2000) (54)
- The PANDAS hypothesis: Losing its bite? (2004) (53)
- Transient tic disorder and the spectrum of Tourette's syndrome. (1988) (52)
- The time course and magnitude of spontaneous recovery of parkinsonism produced by intracarotid administration of 1‐Methyl‐4‐Phenyl‐1,2,3,6‐tetrahydropyridine to monkeys (1991) (51)
- A longitudinal program for biomarker development in Parkinson's disease: A feasibility study (2009) (50)
- Asymmetry of basal ganglia perfusion in Tourette's syndrome shown by technetium-99m-HMPAO SPECT. (1997) (50)
- Exclusion of close linkage of Tourette's syndrome to D1 dopamine receptor. (1993) (50)
- Effect of Urate-Elevating Inosine on Early Parkinson Disease Progression: The SURE-PD3 Randomized Clinical Trial. (2021) (47)
- Pilot study of effect of emotional stimuli on tic severity in children with Tourette's syndrome (2003) (47)
- Phenotypic spectrum and sex effects in eleven myoclonus‐dystonia families with ε‐sarcoglycan mutations (2008) (46)
- D2 dopamine receptor alleles do not influence severity of Tourette's syndrome. Results from four large kindreds. (1994) (44)
- A multicenter randomized placebo‐controlled clinical trial of pramipexole for Tourette's syndrome (2012) (41)
- TREATMENT OF TICS (1997) (40)
- Ecopipam, a D1 receptor antagonist, for treatment of tourette syndrome in children: A randomized, placebo‐controlled crossover study (2018) (40)
- Worsening of motor function and mood in a patient with Parkinson's disease after pharmacologic challenge with oral rivastigmine. (2002) (39)
- An open‐label trial of fluoxetine for obsessive‐compulsive disorder in Gilles de la Tourette's syndrome (1991) (38)
- Cerebrospinal fluid correlates of depression in Huntington's disease. (1988) (38)
- Carbamazepine-induced tics. (1989) (37)
- Tourette's syndrome and 'PANDAS': will the relation bear out? Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection. (1998) (37)
- Myoclonus and dystonia: a family study. (1988) (37)
- The early course of the Tourette's syndrome clinical spectrum (1993) (36)
- A controlled trial of lazabemide (Ro 19-6327) in levodopa-treated Parkinson's disease. Parkinson Study Group. (1994) (35)
- Tourette’s syndrome: Are stimulants safe? (2003) (35)
- Treatment of Tourette Syndrome (2013) (34)
- Quality of Life and Well-Being (2005) (32)
- Treatment of ADHD in children with tics (2002) (32)
- Familial paroxysmal dystonic choreoathetosis: A family study (1987) (31)
- Medication tolerance and augmentation in restless legs syndrome: The need for drug class rotation (2006) (30)
- The dopamine transporter protein gene (SLC6A3): primary linkage mapping and linkage studies in Tourette syndrome. (1995) (30)
- Familial paroxysmal dystonic choreoathetosis and response to alternate‐day oxazepam therapy (1983) (30)
- “Fear of Falling” Gait: A Potentially Reversible Psychogenic Gait Disorder (2005) (29)
- Tics and its disorders. (2001) (29)
- Psychogenic movement disorder (pseudo-tics) in a patient with Tourette's syndrome. (1992) (27)
- Cyanotic congenital heart disease with suspected stroke. Should all patients receive antibiotics? (1983) (26)
- Synaptic processes and immune-related pathways implicated in Tourette syndrome (2020) (26)
- Atomoxetine treatment of ADHD in children with comorbid Tourette syndrome. (2008) (26)
- Long‐term experience with pergolide therapy of advanced parkinsonism (1985) (26)
- Complex obsessive compulsive and impulsive symptoms in Tourette’s syndrome (2007) (25)
- Methylphenidate to treat ADHD is not contraindicated in children with tics (2002) (25)
- Movement disorder in reflex sympathetic dystrophy: A case proven to be psychogenic by surveillance video monitoring (1997) (25)
- Tourette syndrome in a special education population. Hypotheses. (1992) (24)
- Parkinson's disease: a preliminary study of yohimbine challenge in patients with anxiety. (1999) (24)
- Opiate withdrawal unmasks Tourette's syndrome. (1988) (23)
- Handbook of Tourette's Syndrome and Related Tic and Behavioral Disorders, Second Edition (2004) (22)
- Cerebrospinal fluid homovanillic acid and parkinsonism in Huntington's disease (1988) (22)
- Diagnostic criteria for genetic studies of Tourette syndrome. (1997) (22)
- Linkage studies on Gilles de la Tourette syndrome: what is the strategy of choice? (1995) (20)
- Selegiline and manic behavior in Parkinson's disease. (1992) (20)
- Coexistent Meige's syndrome and myasthenia gravis. A relationship between blinking and extraocular muscle fatigue? (1987) (20)
- Standard guidelines for publication of deep brain stimulation studies in Parkinson's disease (Guide4DBS‐PD) (2010) (20)
- Environmental Risk Factors and Clinical Phenotype in Familial and Sporadic Primary Blepharospasm (2011) (19)
- Contemporary assessment and pharmacotherapy of Tourette syndrome (2006) (19)
- A new presenilin Alzheimer’s disease case confirms the helical alignment of pathogenic mutations in transmembrane domain 5 (2004) (19)
- Dystonia in central pontine myelinolysis without evidence of extrapontine myelinolysis. (1993) (19)
- The Differential Diagnosis of Tic Disorders (2013) (19)
- Drug-induced alzheimerism. (1988) (18)
- Differential diagnosis of facial chorea. (1988) (18)
- The increasingly complex genetics of Tourette's syndrome (1997) (17)
- Could Tourette syndrome be a neurologic manifestation of rheumatic fever? (2001) (17)
- Parkinson's Disease: The Facts (1991) (17)
- Willingness of Parkinson's disease patients to participate in research using internet-based technology. (2012) (16)
- Vertebrobasilar ischemia after total repair of tetralogy of Fallot: significance of subclavian steal created by Blalock-Taussig anastomosis. Vertebrobasilar ischemia after correction of tetralogy of Fallot. (1984) (16)
- New treatments for tics? (2001) (15)
- Movement disorders in women: A review (2014) (15)
- Postural, Bone, and Joint Disorders in Parkinson's Disease (2016) (15)
- Dietary therapy for motor fluctuations in Parkinson's disease. (1987) (15)
- Syncope in children with Tourette's syndrome treated with guanfacine (2006) (15)
- Botulinum toxin a is effective in treating trismus associated with postradiation myokymia and muscle spasm (1995) (15)
- Augmentation in restless legs syndrome: poor response to sudden withdrawal of dopaminergic therapy (2013) (14)
- The under-recognition of depression in Parkinson’s disease (2006) (14)
- A practical approach to remote longitudinal follow‐up of Parkinson's disease: The FOUND study (2014) (14)
- International symposium on early dopamine agonist therapy of Parkinson's disease. (1988) (14)
- Tourette's syndrome and nicotine withdrawal. (1993) (13)
- Opiate therapy and self‐harming behavior in tourette's syndrome (1991) (13)
- Double‐blind assessment of potential pergolide‐induced cardiotoxicity (1986) (13)
- Tai Chi in Parkinson’s Disease: A Preliminary Randomized, Controlled, and Rater-Blinded Study (2015) (13)
- Future and alternative therapies in Tourette syndrome. (2006) (13)
- Clinical research in neurology. From observation to experimentation. (1996) (13)
- Clinical impact of recombinant DNA research on neurogenetic diseases. Report of Mary Jennifer Selznick Workshop, organized by the Hereditary Disease Foundation. (1985) (12)
- Acute parkinsonism induced by the combination of a serotonin reuptake inhibitor and a neuroleptic in adults with Tourette's syndrome (1998) (12)
- A Patient-Led Educational Program on Tourette Syndrome: Impact and Implications for Patient-Centered Medical Education (2014) (12)
- Temporal Course of the Tourette Syndrome Clinical Triad (2014) (11)
- Propriospinal myoclonus due to cord compression in the absence of myelopathy (2010) (11)
- Monoamine oxidase and catechol-O-methyltransferase inhibitors. (1999) (11)
- Handbook of secondary dementias (2006) (11)
- Future direction of research in Tourette syndrome. (1997) (11)
- Declining medication requirement in some patients with advanced Parkinson disease and dementia. (2003) (11)
- Practical therapy of Parkinson's disease. (1987) (11)
- Tic Disorders are Associated With Lower Child and Parent Quality of Life and Worse Family Functioning. (2019) (11)
- A clinically useful definition of stereotypies (2013) (10)
- Behavioral Neurology of Movement Disorders (1996) (10)
- Investigating Tourette Syndrome as a Neurologic Sequela of Rheumatic Fever (1999) (10)
- Clinical equipoise in idiopathic normal pressure hydrocephalus: A survey of physicians on the need for randomized controlled trials assessing the efficacy of cerebrospinal fluid diversion (2013) (10)
- Mood fluctuations in Parkinson’s disease: a pilot study comparing the effects of intravenous and oral levodopa administration (2005) (10)
- Hereditary myoclonus and chorea: The spectrum of hereditary nonprogressive hyperkinetic movement disorders (1987) (10)
- Reduced Number of Pigmented Neurons in the Substantia Nigra of Dystonia Patients? Findings from Extensive Neuropathologic, Immunohistochemistry, and Quantitative Analyses (2015) (10)
- Acute Postinfectious Movement and Psychiatric Disorders in Children and Adolescents (2011) (10)
- Design of a Multisite Study Assessing the Impact of Tic Disorders on Individuals, Families, and Communities. (2017) (10)
- Up and down regulation: clinical significance of nervous system receptor-drug interactions. (1982) (9)
- Tourette syndrome. Treatment of tics. (1997) (9)
- Treatment of movement disorders (1995) (9)
- Postprandial (Reactive) hypoglycemia and restless leg syndrome: Related neurologic disorders? (1998) (9)
- Long-term follow-up of a randomized AAV 2-GAD gene therapy trial for Parkinson ’ s disease (2017) (9)
- Severe compression neuropathy following sudden onset of parkinsonian immobility. (1985) (9)
- Welding and Parkinson disease (2005) (9)
- Complementary Therapies for Parkinson's Disease: What's Promoted, Rationale, Potential Risks and Benefits (2015) (8)
- Elevated Common Variant Genetic Risk for Tourette Syndrome in a Densely Affected Pedigree (2021) (7)
- Hypertrophy of nigral neurons in Torsin1A deletion (DYT1) carriers manifesting dystonia. (2019) (7)
- From Observation to Experimentation (1996) (7)
- Parkinson's disease data and organizing center (2007) (7)
- Difficulties in gene localization for Tourette's syndrome. Clinical aspects. (1989) (7)
- The patients’ perspective: Results of a survey assessing knowledge about and attitudes toward depression in PD (2007) (6)
- Severe bilateral tremor in a liver transplant recipient taking cyclosporine (1998) (6)
- Reply to: Treatment of tics in patients with Tourette syndrome: Recommendations according to the European Society for the Study of Tourette Syndrome (2011) (6)
- Anxiety Symptoms Differ in Youth With and Without Tic Disorders (2020) (6)
- Planning a Patient-Centered Parkinson’s Disease Support Program: Insights from Narrative Medicine (2014) (5)
- Tissue culture evidence for a circulating neurotoxin in Huntington's chorea (1987) (5)
- Comparison of Directigen FLU-A with viral isolation and direct (1991) (5)
- Pseudoparkinsonism: A review of a common nonparkinsonian hypokinetic movement disorder (2013) (4)
- Exercise-related middle cerebral artery territory stroke. (1987) (4)
- Levodopa drug holiday versus drug dosage reduction in Parkinson's disease (1994) (4)
- Spontaneous Movement Disorders in Psychiatric Patients (2008) (4)
- Withdrawal-Emergent Dyskinesias following Varenicline Therapy (2015) (4)
- Regarding “Antibiotic Prophylaxis with Azithromycin or Penicillin for Childhood-Onset Neuropsychiatric Disorders” (2005) (3)
- Estimation of an MCID for AIMS Total Score Change in Tardive Dyskinesia (P4.074) (2018) (3)
- Genetics of Gilles de la tourette syndrome (1992) (3)
- Linkage analysis approach to hereditary movement disorders. (1989) (3)
- Clonidine and methylphenidate were effective for attention deficit hyperactivity disorder in children with comorbid tics (2002) (3)
- Augmentation in Restless Legs Syndrome: Treatment with Gradual Medication Modification (2015) (2)
- Parkinson's Disease and Non-motor Dysfunction (2007) (2)
- Conjugal and familial Lewy body disorders: a report of one family. (2013) (2)
- Interim Analysis of an Open-Label, Multi-Center Study of Ecopipam, a Dopamine D1 Receptor Antagonist, for Tic Reduction in Adults with Tourette Syndrome (P02.058) (2013) (2)
- Developmental Chorea and Dystonia of Infancy (1987) (2)
- Hyperkinetic Movement Disorders (2015) (2)
- The Influence of Chronic Administration of Hypnotics and Analgesics on Rate of Recovery from Inhalation Anesthesia in Rats (1975) (2)
- Dopamine D2 Receptor and Tourette's Syndrome-Reply (1995) (2)
- Uncommon Causes of Movement Disorders: Tourette syndrome and other tic disorders (2011) (1)
- Do Parkinson's disease and dementia with Lewy bodies differ by route of environmental precipitant? (2008) (1)
- Early Clinical Predictors of Treatment‐Resistant and Functional Outcomes in Parkinson's Disease (2016) (1)
- Deep Brain Stimulation for Autism Spectrum Disorder: Current and Future Uses (2016) (1)
- AND CATECHOL-O- (1999) (1)
- Risk Behaviors in Youth With and Without Tourette Syndrome. (2021) (1)
- Inheritance and Segregation Pattern of Tourette's Syndrome (1987) (1)
- 4.36 A Randomized, Double-Blind, Placebo-Controlled Study of the D1 Receptor Antagonist Ecopipam for Children and Adolescents With Tourette's Disorder (2017) (1)
- Postoperative and Postpartum Onset of Chronic Parkinsonism: Four Case Reports (2014) (1)
- Neurology supplements and conference reports (2004) (1)
- Executive dysfunction in tourette syndrome: The role of comorbidity (1997) (1)
- Extrapyramidal or pseudoextrapyramidal signs in Alzheimer's disease? (1998) (1)
- Differentiating dementia with lewy bodies from Alzheimer's disease and Parkinson's disease: Potential for the Cambridge neuropsychological test automated batteries (2000) (0)
- Tics and Shorter Stature: Should We Be Looking for an Association? (2014) (0)
- Restless Legs Syndrome (2015) (0)
- Commentary to cognitive and behavioral heterogeneity (2000) (0)
- Psychogenic Hyperkinetic Movement Disorders (2015) (0)
- Mild cerebrospinal fluid pleocytosis in a Parkinson’s disease patient with deep brain stimulation (2014) (0)
- Genome-Wide Association Study of Gilles de la Tourette Syndrome (IN10-1.002) (2012) (0)
- Chapter 131 – Tics and Tourette's Syndrome (2003) (0)
- Principles of Drug Therapy in Neurology (1993) (0)
- Disorders of movement: Clinical, pharmacological and physiological aspects edited By N. P. Quinn, MD, and P. G. Jenraer, MD Orlando, FL, Academic Press, 1989 567 pp, illustrated, $60.00 (1990) (0)
- Editorial (2007) (0)
- Abstracts from the ASENT 2009 Annual Meeting March 5–7, 2009 (2009) (0)
- Willingness of Parkinson Disease Patients To Participate in Research Using Internet-Based Technology (P02.243) (2012) (0)
- Tourette’s Syndrome and Other TIC Disorders (2015) (0)
- Abstract #7: Identifying Potential Subjects for Tourette Syndrome Clinical Research (2009) (0)
- The Role of Group A β-Hemolytic Streptococcal Infection in Neuropsychiatric Disorders: In Reply (2008) (0)
- Short Communications Vertebrobasilar Ischemia After Total Repair of Tetralogy of Fallot: Significance of Subclavian Steal Created by Blalock-Taussig Anastomosis Vertebrobasilar Ischemia After Correction of Tetralogy of Fallot (2005) (0)
- Computer-Simulations on Families with Gilles-De-La-Tourette Syndrome (1993) (0)
- Genome-Wide Association Study of Gilles de la Tourette Syndrome (2012) (0)
- Habits, Mannerisms, Compulsions, and Stereotypies (2015) (0)
- Two Patients with Migraine and Parkinsonism : A Possible Relationship ? (2016) (0)
- Anxiety Symptoms Differ in Youth With and Without Tic Disorders (2020) (0)
- A jejunal pouch technique in the rhesus monkey and related clinical observations. (1992) (0)
- Is it PD or DLB? Timing is everything (2008) (0)
- Genome-wide Association Study Points to Novel Locus for Gilles de la Tourette Syndrome (2023) (0)
- Treatment of Tourette Syndrome (2013) (0)
- Hereditary Myoclonus and Chorea (1987) (0)
- The Basal Ganglia (2015) (0)
- Polygenic risk score-based phenome-wide association study identifies novel associations for Tourette syndrome (2022) (0)
- P.6.039 Atomoxetine treatment in children with attention-deficit/hyperactivity disorder and comorbid tic disorders (2004) (0)
- Movement Disorders Tourette ’ s Disorder (2010) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Roger M. Kurlan?
Roger M. Kurlan is affiliated with the following schools:
